Matthew Block, MD, PHD
NPI 1356359111 · Medical Oncology Physician · Rochester, MN
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1356359111
- Entity type
- Individual
- Primary specialty
- Medical Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, PHD
- Sex
- Male
- Sole proprietor
- No
- License
- 48572 (MN)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,545 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Injection of Additional New Drug Or Substance Into Vein96375 | 369 | $16 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 276 | $132 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 142 | $130 |
| Administration of Non-Hormonal Anti-Neoplastic Chemotherapy Under Skin Or Into Muscle96401 | 92 | $74 |
| Administration of Additional New Drug Or Substance Into Vein, 1 Hour Or Less96417 | 92 | $66 |
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, Additional Sequential Infusion, 1 Hour Or Less96367 | 85 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Binimetinibbrand: Mektovi | 39 | — |
| Encorafenibbrand: Braftovi | 38 | — |
| Olaparibbrand: Lynparza | 27 | — |
| Prednisone | 25 | — |
| Olanzapine | 15 | — |
| Levothyroxine Sodium | 14 | — |
| Prochlorperazine Maleate | 14 | 12 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-08-04
- Last updated
- 2020-08-12
- Certified
- 2020-08-12
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.